Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our opinions or reviews. Learn how we make money.
Updated . What changed?
C4 Therapeutics, Inc. is an other business based in the US. C4 Therapeutics shares (CCCC) are listed on the NASDAQ and all prices are listed in US Dollars. C4 Therapeutics employs 88 staff and has a trailing 12-month revenue of around USD$30.1 million.
|Latest market close||USD$26.1|
|52-week range||USD$19 - USD$28.75|
|50-day moving average||USD$24.6809|
|200-day moving average||USD$24.6809|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||N/A|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2020-10-15)||3.12%|
|1 month (2020-09-18)||N/A|
|3 months (2020-07-18)||N/A|
|6 months (2020-04-18)||N/A|
|1 year (2019-10-18)||N/A|
|2 years (2018-10-18)||N/A|
|3 years (2017-10-18)||N/A|
|5 years (2015-10-18)||N/A|
|Revenue TTM||USD$30.1 million|
|Gross profit TTM||USD$21.4 million|
|Return on assets TTM||0%|
|Return on equity TTM||0%|
|Market capitalisation||USD$1 billion|
TTM: trailing 12 months
We're not expecting C4 Therapeutics to pay a dividend over the next 12 months.
C4 Therapeutics, Inc., a biopharmaceutical company, develops novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable degrader targeting IKZF1/3 for multiple myeloma, peripheral T-cell lymphoma, and mantle cell lymphoma. The company is also developing CFT8634, an orally bioavailable degrader of BRD9, a protein target for synovial sarcoma and SMARCB1-deleted solid malignancies; and BRAF V600E and RET programs for genetically defined resistant solid tumors. It has strategic collaborations with F. Hoffman-La Roche Ltd.; Biogen, Inc.; and Calico Life Sciences LLC. C4 Therapeutics, Inc. was founded in 2015 and is headquartered in Watertown, Massachusetts.
Steps to owning and managing MHO, with 24-hour and historical pricing before you buy.
Steps to owning and managing HLIT, with 24-hour and historical pricing before you buy.
Steps to owning and managing XELA, with 24-hour and historical pricing before you buy.
Steps to owning and managing PDD, with 24-hour and historical pricing before you buy.
Steps to owning and managing JAKK, with 24-hour and historical pricing before you buy.
Steps to owning and managing IMMU, with 24-hour and historical pricing before you buy.
Steps to owning and managing PRCP, with 24-hour and historical pricing before you buy.
Steps to owning and managing MNRO, with 24-hour and historical pricing before you buy.
Steps to owning and managing AMRX, with 24-hour and historical pricing before you buy.
Steps to owning and managing YUM, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.